Drug development and research tools in this category use AI to support target identification, hit‑to‑lead and lead optimisation, trial design, and translational research across the R&D lifecycle. These AI solutions in healthcare typically operate on multi‑omics, preclinical, clinical, and real‑world datasets to prioritise hypotheses, design studies, and de‑risk portfolios. Key evaluation angles include scientific validity and reproducibility, data and IP governance, integration with existing discovery and development workflows, and regulatory and organisational readiness for adoption.
Browse the AI tools below to identify the Drug Development and Research solutions that best match your data, workflow, and governance requirements.
This category page is for informational purposes only and does not constitute regulatory, clinical, or investment advice; organisations should conduct their own technical, legal, and governance due diligence before selecting any AI solutions in healthcare.
